Review decisions

Showing 60 results of 287 total
Summary Safety Review - Artemisia annua -containing Products - Assessing the Potential Risk of Liver Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00262
Issued / Original Publication Date: 2021-03-24
Summary Safety Review - Diuretics, Including Acetazolamide - Assessing the Potential Risk of Certain Eye Disorders
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00261
Issued / Original Publication Date: 2021-03-19
Summary safety review - Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept) and Erelzi (biosimilar etanercept) - Assessing the Potential Risk of Mycosis Fungoides
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00260
Issued / Original Publication Date: 2021-03-18
Summary Safety Review - Cefuroxime-containing products - Assessing the Potential Risk of Kounis Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00259
Issued / Original Publication Date: 2021-03-04
Summary Safety Review - Ceftriaxone-containing products - Assessing the Potential Risk of Encephalopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00257
Issued / Original Publication Date: 2021-02-03
Summary Safety Review - Tecentriq (atezolizumab) - Assessing the Potential Risk of Autoimmune Hemolytic Anemia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00258
Issued / Original Publication Date: 2021-02-03
Summary Safety Review - Sofosbuvir-containing products - Assessing the Potential Risk of Severe Cutaneous Adverse Reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00256
Issued / Original Publication Date: 2021-01-27
Summary Safety Review - Tamiflu (oseltamivir) and generics - Assessing the Potential Risk of Haemorrhages
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00255
Issued / Original Publication Date: 2021-01-08
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Trea™ent Discontinuation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00254
Issued / Original Publication Date: 2021-01-06
Summary Safety Review - Tramadol-containing products - Assessing the Potential Risk of Hallucinations
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00253
Issued / Original Publication Date: 2020-12-29

Displaying 51 - 60 of 287 | Page 6 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: